1
|
Zandian FK, Balalaie S, Amiri K, Bagheri H. Mesoporous organosilicas with highly-content tyrosine framework as extractive phases for non-steroidal anti-inflammatory drugs in aquatic media. Anal Chim Acta 2024; 1290:342206. [PMID: 38246742 DOI: 10.1016/j.aca.2024.342206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2023] [Revised: 12/27/2023] [Accepted: 01/02/2024] [Indexed: 01/23/2024]
Abstract
BACKGROUND Attentions regarding ordered mesoporous silica materials (OMSs), with large specific surface areas and narrow pore size distribution, which are prepared via self-assembly techniques, have been raised in sorption, separation, and sample preparation. However, in order to extend and improve their applications, a functionalization step is required. Organic units can be anchored on the inner or outer surface as well as in the silica wall framework by co-condensation-, grafting-, and periodic mesoporous organosilica (PMO) preparation approaches. Apparently, by synthesizing PMO with extensive and flexible organic bridging groups within the mesoporous wall, an efficient extractive phase can be achieved. RESULTS We employed tyrosine amino acid to synthesize a PMO-based extractive phase. The FT-IR, 1H NMR, HR-ESI-MS, Low angle-XRD, TEM, FESEM, BET, and EDX-MAP analyses confirmed the successful synthesis of PMO within the salt-assisted templating method. A comprehensive study on sorption behavior of PMO was performed and its efficiency was evaluated against the grafting and co-condensation methods. Then, it was implemented to the pipette tip-micro solid phase extraction (PT-μ-SPE) of widely used non-steroidal anti-inflammatory drugs (NSAIDs) in water/wastewaters. Limits of detection and quantification were obtained in the range of 0.1-1.5 and 0.3-5 μg L-1, respectively. The calibration plots are linear in the 1-1000, 3-1000, 10-750, and 3-750 μg L-1, respectively. The intra-and inter-day precision at 50 and 200 μg L-1 levels are 2.9-7.1 % and 3.5-8%, while recoveries are between 84 and 111 %. SIGNIFICANCE High-capacity tyrosine functionalized PMO with 2D hexagonal symmetry silica mesoporous structures found to be highly efficient extractive media. Despite the bulkiness and flexibility of the bridging group within the mesoporous wall, the synthesis condition was optimized in order to load more organic content in the PMO structure. The PMO performance was superior over organically modified ordered mesoporous silica materials prepared by the grafting and co-condensation methods.
Collapse
Affiliation(s)
- F Karimi Zandian
- Environmental and Bio-Analytical Laboratories, Department of Chemistry, Sharif University of Technology, P.O. Box 11365-9516, Tehran, Iran
| | - S Balalaie
- Peptide Chemistry Research Institute, Department of Chemistry, K. N. Toosi University of Technology, P. O. Box 15875-4416, Tehran, Iran
| | - K Amiri
- Peptide Chemistry Research Institute, Department of Chemistry, K. N. Toosi University of Technology, P. O. Box 15875-4416, Tehran, Iran
| | - H Bagheri
- Environmental and Bio-Analytical Laboratories, Department of Chemistry, Sharif University of Technology, P.O. Box 11365-9516, Tehran, Iran.
| |
Collapse
|
2
|
Noghanibehambari H, Bagheri H, Salari M, Tavassoli N, Javid R, Toranji M. Breathing in the future: prenatal exposure to air pollution and infants' health outcomes in the USA. Public Health 2023; 225:198-205. [PMID: 37939461 PMCID: PMC10842113 DOI: 10.1016/j.puhe.2023.10.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2023] [Revised: 09/04/2023] [Accepted: 10/05/2023] [Indexed: 11/10/2023]
Abstract
OBJECTIVES This study aimed to investigate the impact of air pollution on birth outcomes in the USA over several decades. STUDY DESIGN Approximately 70 million birth records were assessed for the years 1980-2020. This study focussed on seven measures of birth outcomes, including birth weight, low birth weight, very low birth weight, full-term birth weight, foetal growth, gestational age and very premature birth. METHODS An instrumental variable identification strategy was used that exploited within county-month and within month-year of birth variations in exposure to precipitation-induced changes in air pollution. RESULTS Air pollution was found to have negative and large effects on a wide range of birth outcomes. The study findings suggest that a one-standard-deviation increase in ozone was associated with a 6.4% and 12.8% increase (from the mean) in the proportion of low birth weight and very preterm birth infants, respectively. Further analyses suggest that these effects were heterogeneous across trimesters of pregnancy and reveal larger impacts during the second and third trimesters. CONCLUSIONS The results suggest that the ordinary least square estimates of previous studies considerably underestimate the true effects of pollution on birth outcomes. Policies that aim to improve the health capital of future generations should allocate more resources and initiatives to improving environmental air quality.
Collapse
Affiliation(s)
- H Noghanibehambari
- Center for Demography of Health and Aging, University of Wisconsin-Madison, Madison, WI 53706, USA.
| | - H Bagheri
- Medical Plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
| | - M Salari
- Department of Accounting, Finance, and Economics, California State University Dominguez Hills, Carson, CA 90747, USA.
| | - N Tavassoli
- Department of Economics, University of Wisconsin Milwaukee, Milwaukee, WI 53211, USA.
| | - R Javid
- School of Engineering, University of Southern California, Los Angeles, CA 90089, USA
| | - M Toranji
- Department of Economics, University of Tehran, Tehran, Iran.
| |
Collapse
|
3
|
Maletz A, Kang G, Chinn RY, Malone JD, Bagheri H, Turner MM, Perez E, Hose M, Shah S, Zeller M, Anderson K, McDonald E, Ruegg J, Brackman S. 432. An Outbreak of Coronavirus Disease, 2019 (COVID-19) in a Skilled Nursing Facility – California, 2021: Description, Mitigation, Challenges, and Opportunities. Open Forum Infect Dis 2021. [PMCID: PMC8644286 DOI: 10.1093/ofid/ofab466.632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Skilled nursing facility (SNF) residents comprised 11% of all COVID-19 cases in the United States; however, they account for 43% of deaths with case fatality rates (CFR) of 26.0-33.7%.
Methods
We report an outbreak of COVID-19, from June 15 to July 21, 2020 in a 159-bed SNF with a staff of 172 that resulted in an infection rate of 97% in residents and 23% in HCWs (Figure 1). A retroactive review outlined mitigation efforts, discussed challenges, identified risk factors among residents and health care workers (HCW) for acquisition of COVID-19, and reviewed opportunities for improvement (Figure 2).
Figure 1. Epi Curve of COVID-19 Outbreak in a Skilled Nursing Facility
Figure 2. Timeline of COVID-19 Outbreak in a Skilled Nursing Facility
Results
Factors that contributed to the outbreak: delay in test results had an impact on cohorting; suboptimal adherence to the principles of infection prevention and control (IPC) and minimal adherence monitoring; strict criteria were used to screen for infection; the underappreciated transmissibility of COVID-19 from presymptomatic and asymptomatic persons; symptomatic HCWs who continued to work; the changing guidance on, the suboptimal use of, and an inadequate supply of personal protective equipment; poor indoor air quality due to ventilation challenges; and the important role of community/family/interfacility spread on the outbreak. Whole genome sequencing, performed in 52 samples, identified a common strain that was also found in clusters of 2 other facilities: 1 in the same geographic location, the other in a different geographic location but whose HCWs had the same zip codes as the facility (Figure 3). Certified nursing and restorative nursing assistants had the highest risk of infection with an odds ratio (OR) of 4.02 (confidence interval 1.29-12.55, p value: 0.02) when compared to registered and licensed vocational nurses. The residents’ CFR was 24%. The OR for death was increased by 10.5 (10.20-11.00) for every decade of life as was morbid obesity (BMI > 35) with an OR of 8.50. BMI as a continuous variable increased risk of mortality for every additional unit, OR 1.07 (Tables 1, 2).
Whole Genome Sequencing of Isolates from a Skilled Nursing Facility Outbreak
Univariate Analysis of Selected Variables Associated with Mortality among Residents at Facility A during COVID-19 Outbreak, June 19 - July 21, 2021
Multivariate Analysis of Factors Associated with Mortality from COVID-19 after Adjusting for Age among Residents (N =124) of Facility A, June 15 - July 21, 2020
Conclusion
While implementation of optimal IPC measures in the pre-COVID-19 vaccination era had no impact on the infections in residents who were likely already infected or exposed at the onset of the outbreak, these measures along with non-pharmacologic strategies were effective in halting the spread among HCWs.
Disclosures
All Authors: No reported disclosures
Collapse
Affiliation(s)
| | - Grace Kang
- County of San Diego, Epidemiology & Immunization Services Branch, San Diego, California
| | - Raymond Y Chinn
- County of San Diego, Health and Human Services Agency, San Diego, California
| | - John D Malone
- County of San Diego, Health and Human Services Agency, San Diego, California
| | - Hosniyeh Bagheri
- California Department of Public Health (CDPH), Rancho Santa Margarita, CA
| | | | - Elizar Perez
- County of San Diego, Epidemiology & Immunization Services Branch, San Diego, California
| | - Michelle Hose
- California Department of Public Health, Center for Healthcare Quality, San Diego, California
| | - Seema Shah
- County of San Diego, Health and Human Services Agency, San Diego, California
| | - Mark Zeller
- The Scripps Research Institute, San Diago, California
| | | | | | | | | |
Collapse
|
4
|
Karmarkar EN, O'Donnell K, Prestel C, Forsberg K, Gade L, Jain S, Schan D, Chow N, McDermott D, Rossow J, Toda M, Ruiz R, Hun S, Dale JL, Gross A, Maruca T, Glowicz J, Brooks R, Bagheri H, Nelson T, Gualandi N, Khwaja Z, Horwich-Scholefield S, Jacobs J, Cheung M, Walters M, Jacobs-Slifka K, Stone ND, Mikhail L, Chaturvedi S, Klein L, Vagnone PS, Schneider E, Berkow EL, Jackson BR, Vallabhaneni S, Zahn M, Epson E. Rapid Assessment and Containment of Candida auris Transmission in Postacute Care Settings-Orange County, California, 2019. Ann Intern Med 2021; 174:1554-1562. [PMID: 34487450 PMCID: PMC10984253 DOI: 10.7326/m21-2013] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND Candida auris, a multidrug-resistant yeast, can spread rapidly in ventilator-capable skilled-nursing facilities (vSNFs) and long-term acute care hospitals (LTACHs). In 2018, a laboratory serving LTACHs in southern California began identifying species of Candida that were detected in urine specimens to enhance surveillance of C auris, and C auris was identified in February 2019 in a patient in an Orange County (OC), California, LTACH. Further investigation identified C auris at 3 associated facilities. OBJECTIVE To assess the prevalence of C auris and infection prevention and control (IPC) practices in LTACHs and vSNFs in OC. DESIGN Point prevalence surveys (PPSs), postdischarge testing for C auris detection, and assessments of IPC were done from March to October 2019. SETTING All LTACHs (n = 3) and vSNFs (n = 14) serving adult patients in OC. PARTICIPANTS Current or recent patients in LTACHs and vSNFs in OC. INTERVENTION In facilities where C auris was detected, PPSs were repeated every 2 weeks. Ongoing IPC support was provided. MEASUREMENTS Antifungal susceptibility testing and whole-genome sequencing to assess isolate relatedness. RESULTS Initial PPSs at 17 facilities identified 44 additional patients with C auris in 3 (100%) LTACHs and 6 (43%) vSNFs, with the first bloodstream infection reported in May 2019. By October 2019, a total of 182 patients with C auris were identified by serial PPSs and discharge testing. Of 81 isolates that were sequenced, all were clade III and highly related. Assessments of IPC identified gaps in hand hygiene, transmission-based precautions, and environmental cleaning. The outbreak was contained to 2 facilities by October 2019. LIMITATION Acute care hospitals were not assessed, and IPC improvements over time could not be rigorously evaluated. CONCLUSION Enhanced laboratory surveillance and prompt investigation with IPC support enabled swift identification and containment of C auris. PRIMARY FUNDING SOURCE Centers for Disease Control and Prevention.
Collapse
Affiliation(s)
- Ellora N Karmarkar
- Epidemic Intelligence Service Program, Centers for Disease Control and Prevention, Atlanta, Georgia, and the California Department of Public Health, Richmond, California (E.N.K.)
| | - Kathleen O'Donnell
- Orange County Health Care Agency, Santa Ana, California (K.O., D.S., J.J., M.C., L.M., M.Z.)
| | - Christopher Prestel
- Epidemic Intelligence Service Program, Centers for Disease Control and Prevention, Atlanta, Georgia (C.P., J.R., M.T.)
| | - Kaitlin Forsberg
- Centers for Disease Control and Prevention and IHRC, Atlanta, Georgia (K.F.)
| | - Lalitha Gade
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - Seema Jain
- California Department of Public Health, Richmond, California (S.J., H.B., T.N., Z.K., S.H., E.E.)
| | - Douglas Schan
- Orange County Health Care Agency, Santa Ana, California (K.O., D.S., J.J., M.C., L.M., M.Z.)
| | - Nancy Chow
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - Darby McDermott
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - John Rossow
- Epidemic Intelligence Service Program, Centers for Disease Control and Prevention, Atlanta, Georgia (C.P., J.R., M.T.)
| | - Mitsuru Toda
- Epidemic Intelligence Service Program, Centers for Disease Control and Prevention, Atlanta, Georgia (C.P., J.R., M.T.)
| | - Ryan Ruiz
- Washington State Public Health Laboratories, Shoreline, Washington (R.R., S.H., E.S.)
| | - Sopheay Hun
- Washington State Public Health Laboratories, Shoreline, Washington (R.R., S.H., E.S.)
| | - Jennifer L Dale
- Minnesota Department of Health Public Health Laboratory, St. Paul, Minnesota (J.L.D., A.G., P.S.V.)
| | - Annastasia Gross
- Minnesota Department of Health Public Health Laboratory, St. Paul, Minnesota (J.L.D., A.G., P.S.V.)
| | - Tyler Maruca
- Maryland Department of Health Laboratories Administration, Baltimore, Maryland (T.M., L.K.)
| | - Janet Glowicz
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - Richard Brooks
- Centers for Disease Control and Prevention, Atlanta, Georgia, and the Maryland Department of Health, Infectious Disease Epidemiology and Outbreak Response Bureau, Baltimore, Maryland (R.B.)
| | - Hosniyeh Bagheri
- California Department of Public Health, Richmond, California (S.J., H.B., T.N., Z.K., S.H., E.E.)
| | - Teresa Nelson
- California Department of Public Health, Richmond, California (S.J., H.B., T.N., Z.K., S.H., E.E.)
| | - Nicole Gualandi
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - Zenith Khwaja
- California Department of Public Health, Richmond, California (S.J., H.B., T.N., Z.K., S.H., E.E.)
| | - Sam Horwich-Scholefield
- California Department of Public Health, Richmond, California (S.J., H.B., T.N., Z.K., S.H., E.E.)
| | - Josh Jacobs
- Orange County Health Care Agency, Santa Ana, California (K.O., D.S., J.J., M.C., L.M., M.Z.)
| | - Michele Cheung
- Orange County Health Care Agency, Santa Ana, California (K.O., D.S., J.J., M.C., L.M., M.Z.)
| | - Maroya Walters
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - Kara Jacobs-Slifka
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - Nimalie D Stone
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - Lydia Mikhail
- Orange County Health Care Agency, Santa Ana, California (K.O., D.S., J.J., M.C., L.M., M.Z.)
| | | | - Liore Klein
- Maryland Department of Health Laboratories Administration, Baltimore, Maryland (T.M., L.K.)
| | - Paula Snippes Vagnone
- Minnesota Department of Health Public Health Laboratory, St. Paul, Minnesota (J.L.D., A.G., P.S.V.)
| | - Emily Schneider
- Washington State Public Health Laboratories, Shoreline, Washington (R.R., S.H., E.S.)
| | - Elizabeth L Berkow
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - Brendan R Jackson
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - Snigdha Vallabhaneni
- Centers for Disease Control and Prevention, Atlanta, Georgia (L.G., N.C., D.M., J.G., N.G., M.W., K.J., N.D.S., E.L.B., B.R.J., S.V.)
| | - Matthew Zahn
- Orange County Health Care Agency, Santa Ana, California (K.O., D.S., J.J., M.C., L.M., M.Z.)
| | - Erin Epson
- California Department of Public Health, Richmond, California (S.J., H.B., T.N., Z.K., S.H., E.E.)
| |
Collapse
|
5
|
Montastruc G, Despas F, Rousseau V, Lafaurie M, De Canecaude C, Durrieu G, Montastruc F, Bagheri H, Montastruc J. Lipid-lowering drugs and the risk of cataract: An Observational Post Marketing Study. Archives of Cardiovascular Diseases Supplements 2020. [DOI: 10.1016/j.acvdsp.2019.09.419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
6
|
Karmarkar E, Karmarkar E, O’Donnell K, Prestel C, Forsberg K, Forsberg K, Schan DK, Chow NA, McDermott DS, Rossow JA, Toda M, Toda M, Glowicz J, Brooks R, Brooks R, Bagheri H, Nelson T, Gualandi N, Khwaja Z, Horwich-Scholefield S, Jacobs J, Cheung M, Mikhail L, Walters MS, Walters MS, Jacobs-Slifka K, Stone ND, Stone ND, Gade L, Berkow EL, Berkow EL, Jackson BR, Jackson BR, Vallabhaneni S, Vallabhaneni S, Zahn M, Epson E, Epson E. LB1. Regional Assessment and Containment of Candida auris Transmission in Post-Acute Care Settings—Orange County, California, 2019. Open Forum Infect Dis 2019. [PMCID: PMC6810421 DOI: 10.1093/ofid/ofz415.2484] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Patients in long-term acute care hospitals (LTACHs) and skilled nursing facilities with ventilator units (VSNFs) are at high risk for Candida auris colonization; among patients colonized with this emerging pathogen, 5%–10% develop invasive disease with >45% mortality. In September 2018, a California LTACH-affiliated laboratory began enhanced C. auris surveillance by classifying species of Candida isolated from routine urine specimens. In February 2019, the first known Southern California case was detected in an Orange County (OC) LTACH; the patient had not traveled outside the region, indicating local acquisition. We performed point prevalence surveys (PPS) and infection prevention (IP) assessments at all OC LTACHs and VSNF subacute units to identify patients colonized with C. auris and control transmission.
Methods
During March–August 2019, we conducted PPS at facilities by collecting composite axilla and groin swabs for C. auris polymerase chain reaction testing and reflex culture from all patients who assented. Facilities with ≥1 C. auris-colonized patient repeated a PPS every 2 weeks to assess for new transmission. Isolate relatedness was assessed by whole-genome sequencing (WGS). We evaluated hand hygiene (HH) adherence, access to alcohol-based hand rubs (ABHR), and cleaning of high-touch surfaces to guide IP recommendations.
Results
The first PPS at all OC LTACHs (n = 3) and adult VSNFs (n = 14) identified 45 C. auris-colonized patients in 3 (100%) LTACHs and 6 (43%) VSNFs; after repeated PPS, the total count reached 124. Most patients (70%) were at 2 facilities (Table 1). Three of 124 patients developed candidemia. To date, isolates from 48 patients have completed WGS; all were highly related (<11 single-nucleotide polymorphisms) in the African clade. Of 9 facilities with C. auris, 5 had HH adherence < 50%, 3 had limited ABHR, and at 2, <60% of assessed high-touch surfaces were clean. We recommended regular HH and cleaning audits, and increased ABHR.
Conclusion
Our investigation, prompted by enhanced surveillance, identified C. auris at 9 OC facilities. WGS indicated a single introduction and local transmission. Early detection, followed by rapid county-wide investigation and IP support, enabled containment efforts for C. auris in OC.
Disclosures
All authors: No reported disclosures.
Collapse
Affiliation(s)
- Ellora Karmarkar
- Centers for Disease Control and Prevention, Richmond, California
| | - Ellora Karmarkar
- Centers for Disease Control and Prevention, Richmond, California
| | | | | | - Kaitlin Forsberg
- Centers for Disease Control and Prevention; IHRC, Inc., Atlanta, Georgia
| | - Kaitlin Forsberg
- Centers for Disease Control and Prevention; IHRC, Inc., Atlanta, Georgia
| | | | | | | | - John A Rossow
- Centers for Disease Control and Prevention, Richmond, California
| | - Mitsuru Toda
- Centers for Disease Control and Prevention, Richmond, California
| | - Mitsuru Toda
- Centers for Disease Control and Prevention, Richmond, California
| | - Janet Glowicz
- Centers for Disease Control and Prevention, Richmond, California
| | - Richard Brooks
- Centers for Disease Control and Prevention, Richmond, California
| | - Richard Brooks
- Centers for Disease Control and Prevention, Richmond, California
| | - Hosniyeh Bagheri
- California Department of Public Health (CDPH), Rancho Santa Margarita, California
| | - Teresa Nelson
- California Department of Public Health, Redlands, California
| | | | | | | | - Joshua Jacobs
- Orange County Health Care Agency, Los Angeles, California
| | - Michele Cheung
- Orange County Health Care Agency, Los Angeles, California
| | - Lydia Mikhail
- Orange County Health Care Agency, Los Angeles, California
| | - Maroya S Walters
- Centers for Disease Control and Prevention, Richmond, California
| | - Maroya S Walters
- Centers for Disease Control and Prevention, Richmond, California
| | | | - Nimalie D Stone
- CDC Division of Healthcare Quality and Promotion, Atlanta, Georgia
| | - Nimalie D Stone
- CDC Division of Healthcare Quality and Promotion, Atlanta, Georgia
| | | | | | | | | | | | | | | | - Matt Zahn
- Orange County Health Care Agency, Los Angeles, California
| | - Erin Epson
- California Department of Public Health, Redlands, California
| | - Erin Epson
- California Department of Public Health, Redlands, California
| |
Collapse
|
7
|
Bataillard M, Beyens M, Mounier G, Vergnon D, Bagheri H, Cathébras P. Atteintes musculaires liées à l’interaction acide fusidique–statine : revue de 75 cas issus de la base nationale de pharmacovigilance française et de la littérature. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
8
|
Bondon-Guitton E, Combret S, Pérault-Pochat MC, Stève-Dumont M, Bagheri H, Huguet F, Despas F, Pathak A, Montastruc JL. Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapy. Target Oncol 2017; 11:549-52. [PMID: 26891968 DOI: 10.1007/s11523-016-0417-x] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
BACKGROUND Over the past few years, data have suggested that severe peripheral arterial occlusive disease (PAOD) is associated with nilotinib exposure. However, the characteristics of this adverse drug reaction are poorly described since its frequency is low. As far as we know, no study using a spontaneous adverse drug reactions reporting system was performed to describe the characteristics of cases of PAOD related to nilotinib. OBJECTIVE We performed a study to describe the cardiovascular risk profile of cases of PAOD in patients treated with nilotinib spontaneously reported to the French Pharmacovigilance Database (FPVD). PATIENTS/METHODS We selected all cases of "vascular disorders," as the System Organ Class in MedDRA®, in which nilotinib was "suspected" and recorded in the French Pharmacovigilance Database between 2007 and 21 October 2014. We then identified cases of PAOD with a Low Level Term and through a detailed summary of the clinical description. RESULTS We identified 25 cases of POAD. Most of the patients were older than 60 years (84 %) or had another cardiovascular risk factor such as hypercholesterolemia, arterial hypertension, overweight/obesity, smoking, or diabetes mellitus (72 %). Females (13 cases) and males (12 cases) were equally represented, but the presence of cardiovascular risk factors was more frequent in females than in males. The mean time from initiation of nilotinib to PAOD onset was 24 months and was significantly longer in patients aged less than 60 years compared with those aged over 60 years (33.8 ± 24.6 months vs. 22.6 ± 17.5 months, p = 0.002). Pre-existing cardiovascular risk factors, especially diabetes mellitus, also seem to accelerate its occurrence. CONCLUSIONS The FPVD is a useful tool in describing the cardiovascular risk profile of patients with PAOD during nilotinib exposure. Physicians have to be particularly vigilant in patients older than 60 years of age; in patients younger than 60 years of age, long-term surveillance has to be maintained.
Collapse
Affiliation(s)
- E Bondon-Guitton
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de Pharmacovigilance, Pharmacoépidémiologie et Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, CHU Toulouse, Faculté de Médecine de l'Université de Toulouse, Toulouse, France.
| | - S Combret
- Centre Régional de Pharmacovigilance de Bourgogne, Centre Hospitalier Universitaire, Dijon, France
| | - M C Pérault-Pochat
- Pharmacologie Clinique et Vigilances, Centre Hospitalier Universitaire, Poitiers, France
| | - M Stève-Dumont
- Centre Régional de Pharmacovigilance, Hôpital de Cimiez, Nice, France
| | - H Bagheri
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de Pharmacovigilance, Pharmacoépidémiologie et Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, CHU Toulouse, Faculté de Médecine de l'Université de Toulouse, Toulouse, France
| | - F Huguet
- Service d'Hématologie, Institut Universitaire du Cancer, Toulouse, France
| | - F Despas
- Service de Pharmacologie Médicale et Clinique, CHU Toulouse, Faculté de Médecine de l'Université de Toulouse, Toulouse, France
| | - A Pathak
- Service de Pharmacologie Médicale et Clinique, CHU Toulouse, Faculté de Médecine de l'Université de Toulouse, Toulouse, France
| | - J L Montastruc
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de Pharmacovigilance, Pharmacoépidémiologie et Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, CHU Toulouse, Faculté de Médecine de l'Université de Toulouse, Toulouse, France
| |
Collapse
|
9
|
Gholamzadeh Z, Feghhi SAH, Alipoor Z, Vahedi M, Mirvakili SM, Bagheri H, Tenreiro C. Investigation of neutronic and safety parameters variation in 5 MW research reactor due to U 3O 8Al fuel conversion to ThO 2 + U 3O 8Al. KERNTECHNIK 2017. [DOI: 10.3139/124.110636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Affiliation(s)
- Z. Gholamzadeh
- PhD, Reactor Research School, Nuclear Science and Technology Research Institute, Tehran, Iran
| | - S. A. H. Feghhi
- PhD, Department of Radiation Application, Shahid Beheshti University, G.C, Tehran, Iran
| | - Z. Alipoor
- MSc, Reactor Research School, Nuclear Science and Technology
| | - M. Vahedi
- PhD, University of Science and Technology, Energy Department, Tehran, Iran
| | - S. M. Mirvakili
- PhD, Reactor Research School, Nuclear Science and Technology Research Institute, Tehran, Iran
| | - H. Bagheri
- MSc, University of Science and Technology, Energy Department, Tehran, Iran
| | - C. Tenreiro
- PhD, Energy department, Talca University, Talca, Chile
| |
Collapse
|
10
|
Amidi S, Ardakani YH, Amiri-Aref M, Ranjbari E, Sepehri Z, Bagheri H. Sensitive electrochemical determination of rifampicin using gold nanoparticles/poly-melamine nanocomposite. RSC Adv 2017. [DOI: 10.1039/c7ra04865c] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Green and facile method for fabrication of a conductive polymer–Au nanocomposite platform as a novel electrochemical sensing layer for rifampicin.
Collapse
Affiliation(s)
- S. Amidi
- Department of Medicinal Chemistry
- School of Pharmacy & Protein Technology Research Center
- Shahid Beheshti University of Medical Sciences
- Tehran
- Iran
| | - Y. Hosseinzadeh Ardakani
- Biopharmaceutics and Pharmacokinetics Division
- Department of Pharmaceutics
- Faculty of Pharmacy
- Tehran University of Medical Sciences
- Tehran 14155-6451
| | - M. Amiri-Aref
- Biopharmaceutics and Pharmacokinetics Division
- Department of Pharmaceutics
- Faculty of Pharmacy
- Tehran University of Medical Sciences
- Tehran 14155-6451
| | - E. Ranjbari
- Biopharmaceutics and Pharmacokinetics Division
- Department of Pharmaceutics
- Faculty of Pharmacy
- Tehran University of Medical Sciences
- Tehran 14155-6451
| | - Z. Sepehri
- Department of Internal Medicine
- Zabol University of Medical Sciences
- Zabol
- Iran
| | - H. Bagheri
- Chemical Injuries Research Center
- Baqiyatallah University of Medical Sciences
- Tehran
- Iran
| |
Collapse
|
11
|
Guinard E, Bulai Livideanu C, Barthélémy H, Viguier M, Reguiai Z, Richard M, Jullien D, Beneton N, Bara C, Vabres P, Grandvuillemin A, Marguery M, Amelot F, Konstantinou M, Bagheri H, Paul C. Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective study. J Eur Acad Dermatol Venereol 2016; 30:1336-41. [DOI: 10.1111/jdv.13633] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2016] [Accepted: 01/20/2016] [Indexed: 12/17/2022]
Affiliation(s)
- E. Guinard
- Service de dermatologie; CHU Toulouse Larrey; Université Paul Sabatier; Toulouse France
| | - C. Bulai Livideanu
- Service de dermatologie; CHU Toulouse Larrey; Université Paul Sabatier; Toulouse France
| | | | - M. Viguier
- Service de dermatologie; CHU Saint Louis; Paris France
| | - Z. Reguiai
- Service de dermatologie; CHU de Reims; Reims France
| | - M.A. Richard
- Service de dermatologie; Hôpital Timone; Assistance publique des Hôpitaux de Marseille; Université Aix Marseille; Marseille France
- UMR 911; INSERM CRO2, “Centre de recherche en oncologie biologique et onco phamacologie; Marseille France
| | - D. Jullien
- Service de dermatologie; CHU Lyon; Université de Lyon; Lyon France
| | - N. Beneton
- Service de dermatologie; CH du Mans; Le Mans France
| | - C. Bara
- Service de dermatologie; CH du Mans; Le Mans France
| | - P. Vabres
- Service de dermatologie; CHU Dijon; Dijon France
| | | | - M.C. Marguery
- Service de dermatologie; CHU Toulouse Larrey; Université Paul Sabatier; Toulouse France
| | - F. Amelot
- Service de dermatologie; CHU Toulouse Larrey; Université Paul Sabatier; Toulouse France
| | - M.P. Konstantinou
- Service de dermatologie; CHU Toulouse Larrey; Université Paul Sabatier; Toulouse France
| | - H. Bagheri
- Service de pharmacologie médicale et clinique; CHU Toulouse; Toulouse France
| | - C. Paul
- Service de dermatologie; CHU Toulouse Larrey; Université Paul Sabatier; Toulouse France
| | | |
Collapse
|
12
|
Cabarrot A, Montastruc JL, Chebane L, Rousseau V, Bondon-Guitton E, Moulis F, Durrieu G, Bagheri H, Montastruc F. Neurological and digestive bleeding with Direct Oral Anticoagulants versus Vitamin K Antagonists: The differences do not stop there! A pharmacovigilance study. Pharmacol Res 2016; 118:119-120. [PMID: 27265115 DOI: 10.1016/j.phrs.2016.05.024] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Revised: 05/24/2016] [Accepted: 05/25/2016] [Indexed: 10/21/2022]
Affiliation(s)
- A Cabarrot
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, INSERM UMR 1027, CIC INSERM 1436, Centre Hospitalier Universitaire, Faculté de Médecine de Toulouse, France.
| | - J L Montastruc
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, INSERM UMR 1027, CIC INSERM 1436, Centre Hospitalier Universitaire, Faculté de Médecine de Toulouse, France
| | - L Chebane
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, INSERM UMR 1027, CIC INSERM 1436, Centre Hospitalier Universitaire, Faculté de Médecine de Toulouse, France
| | - V Rousseau
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, INSERM UMR 1027, CIC INSERM 1436, Centre Hospitalier Universitaire, Faculté de Médecine de Toulouse, France
| | - E Bondon-Guitton
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, INSERM UMR 1027, CIC INSERM 1436, Centre Hospitalier Universitaire, Faculté de Médecine de Toulouse, France
| | - F Moulis
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, INSERM UMR 1027, CIC INSERM 1436, Centre Hospitalier Universitaire, Faculté de Médecine de Toulouse, France
| | - G Durrieu
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, INSERM UMR 1027, CIC INSERM 1436, Centre Hospitalier Universitaire, Faculté de Médecine de Toulouse, France
| | - H Bagheri
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, INSERM UMR 1027, CIC INSERM 1436, Centre Hospitalier Universitaire, Faculté de Médecine de Toulouse, France
| | - F Montastruc
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, Pharmacoépidémiologie et d'Informations sur le Médicament, Pharmacopôle Midi-Pyrénées, INSERM UMR 1027, CIC INSERM 1436, Centre Hospitalier Universitaire, Faculté de Médecine de Toulouse, France
| |
Collapse
|
13
|
Bagheri H, Nekoomanesh M, Hakim S, Jahani Y, Tan HS, Fan ZQ. Rheology of polypropylene/poly(ethylene-co-propylene) in-reactor alloy. Polym Sci Ser A 2016. [DOI: 10.1134/s0965545x16020024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
14
|
Vancassel M, Jurado C, Eyvrard F, Houet S, Watier M, Alric L, Metivier S, Abravanel F, Bagheri H, Bellon B. CP-146 Drug interactions with direct acting antivirals for hepatitis C: What about in practice? pharmaceutical impact. Eur J Hosp Pharm 2016. [DOI: 10.1136/ejhpharm-2016-000875.146] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
15
|
Bagheri H, Pajooheshpour N, Afkhami A, Khoshsafar H. Fabrication of a novel electrochemical sensing platform based on a core–shell nano-structured/molecularly imprinted polymer for sensitive and selective determination of ephedrine. RSC Adv 2016. [DOI: 10.1039/c6ra09488k] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
A simple methodology was used to develop a novel sensor based on a core–shell/molecularly imprinted polymer (MIP) for the determination of ephedrine.
Collapse
Affiliation(s)
- H. Bagheri
- Chemical Injuries Research Center
- Baqiyatallah University of Medical Sciences
- Tehran
- Iran
| | - N. Pajooheshpour
- Department of Pharmaceutical Chemistry
- Faculty of Pharmaceutical Chemistry
- Pharmaceutical Sciences Branch
- Islamic Azad University
- Tehran
| | - A. Afkhami
- Faculty of Chemistry
- Bu-Ali Sina University
- Hamedan
- Iran
| | - H. Khoshsafar
- Department of Pharmacy
- Zabol University of Medical Sciences
- Zabol
- Iran
| |
Collapse
|
16
|
Alberto C, Konstantinou M, Martinage C, Casassa E, Tournier E, Bagheri H, Sibaud V, Mourey L, Meyer N, Paul C, Bulai Livideanu C. Premier cas de pustulose exanthématique aiguë généralisée survenant sous enzalutamide. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
17
|
Guinard E, Bulai Livideanu C, Barthélémy H, Viguier M, Reguiai Z, Richard MA, Jullien D, Martinelli J, Beneton N, Bara C, Vabres P, Grandvuillemin A, Marguery M, Amelot F, Ofaiche J, Konstantinou MP, Bagheri H, Paul C. Tuberculose active et psoriasis traité par anti-TNF alpha : étude nationale. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
18
|
Legendre L, Payré B, Comont T, Gaches F, Lamant L, Gaulier JM, Livideanu C, Bagheri H, Delisle MB, Paul C, Livideanu CB. « La peau est bleue comme une orange » : dermatopathomimie au carbone. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
19
|
Thorel J, Civade E, Quintyn JC, Cestac P, Montastruc JL, Bagheri H. Ischaemic stroke after exposure to aflibercept: interaction with vitamin K antagonist and/or direct pharmacodynamic effect? J Clin Pharm Ther 2015; 40:477-9. [PMID: 25930164 DOI: 10.1111/jcpt.12278] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2014] [Accepted: 03/24/2015] [Indexed: 01/06/2023]
Abstract
WHAT IS KNOWN AND OBJECTIVE Vascular endothelial growth factor (VEGF) proteins are involved in the regulation of vascular endothelium, and their inhibition led to the development of a number of drugs used for malignancies or exudative neo-vascular age-related macular degeneration (AMD). CASE SUMMARY We report a case of ischemic stroke in an 87-year-old woman having received intravitreal aflibercept, a new anti-VEGF for AMD. She had been treated with ranibizumab since 2007. In 2013, ranibizumab was replaced with aflibercept, followed by a decrease in the International Normalized Ratio, complicated by a stroke a few days later. The rechallenge was positive. WHAT IS NEW AND CONCLUSION A potential time-dependent interaction between aflibercept and VKA antagonist and/or a direct effect of aflibercept may have contributed to the occurrence of the ischaemic stroke. Currently available data suggest some pharmacokinetic and pharmacodynamic effects of aflibercept by explaining its pro-thrombotic profile.
Collapse
Affiliation(s)
- J Thorel
- Department of Pharmacy, Toulouse University Hospital, Toulouse, France
| | - E Civade
- Department of Pharmacy, Toulouse University Hospital, Toulouse, France
| | - J C Quintyn
- Department of Ophthalmology, Toulouse University Hospital, Toulouse, France
| | - P Cestac
- Department of Pharmacy, Toulouse University Hospital, Toulouse, France.,Faculty of Pharmaceutical Sciences, Paul Sabatier University, Toulouse, France
| | - J-L Montastruc
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, CHU de Toulouse, Université de Toulouse, INSERM U1027, Faculté de Médecine, Toulouse, France
| | - H Bagheri
- Service de Pharmacologie Médicale et Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, CHU de Toulouse, Université de Toulouse, INSERM U1027, Faculté de Médecine, Toulouse, France
| |
Collapse
|
20
|
Bagheri H, Afkhami A, Hashemi P, Ghanei M. Simultaneous and sensitive determination of melatonin and dopamine with Fe3O4 nanoparticle-decorated reduced graphene oxide modified electrode. RSC Adv 2015. [DOI: 10.1039/c4ra16802j] [Citation(s) in RCA: 73] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
An electrochemical sensor based on a new nanocomposite of graphene/Fe3O4 has been fabricated for simultaneous determination of melatonin and dopamine.
Collapse
Affiliation(s)
- H. Bagheri
- Chemical Injuries Research Center
- Baqiyatallah University of Medical Sciences
- Tehran
- Iran
| | - A. Afkhami
- Faculty of Chemistry
- Bu-Ali Sina University
- Hamedan
- Iran
| | - P. Hashemi
- Faculty of Chemistry
- Bu-Ali Sina University
- Hamedan
- Iran
| | - M. Ghanei
- Chemical Injuries Research Center
- Baqiyatallah University of Medical Sciences
- Tehran
- Iran
| |
Collapse
|
21
|
Bagheri H, Talemi RP, Afkhami A. Gold nanoparticles deposited on fluorine-doped tin oxide surface as an effective platform for fabricating a highly sensitive and specific digoxin aptasensor. RSC Adv 2015. [DOI: 10.1039/c5ra09402j] [Citation(s) in RCA: 36] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Fabrication steps of digoxin aptasensor. The DPVs are for accumulated MB at FTO/GNPs/Ap, before (a) and after (b) incubation with digoxin.
Collapse
Affiliation(s)
- H. Bagheri
- Chemical Injuries Research Center
- Baqiyatallah University of Medical Sciences
- Tehran
- Iran
| | - R. P. Talemi
- Faculty of Chemistry
- Kharazmi University
- Tehran
- Iran
| | - A. Afkhami
- Faculty of Chemistry
- Bu-Ali Sina University
- Hamedan
- Iran
| |
Collapse
|
22
|
Guinard E, Bulai Livideanu C, Chebane L, Bagheri H, Lahfa M, Marguery M, Hautier Mazereeuw J, Cogny N, Blancher A, Paul C. Tuberculose active chez patients psoriasis traités par anti-TNF alpha : faut-il se méfier des résultats biologiques négatifs ? Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
23
|
Bagheri H, Ibrahim NA, Habil H. The structure of clinical consultation: a case of non-native speakers of English as participants. Glob J Health Sci 2014; 7:249-60. [PMID: 25560336 PMCID: PMC4796523 DOI: 10.5539/gjhs.v7n1p249] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2014] [Accepted: 07/16/2014] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND In many parts of the world, patients may find it difficult to visit doctors who share the same language and culture due to the intermingling of people and international recruitment of doctors among many other reasons. In these multilingual multicultural settings (MMSs), doctor-patient interactions face new communication challenges. This study aims to identify the structure of clinical consultation and its phases in an MMS where both doctors and patients are non-native speakers (NNSs) of English. METHOD This study takes on a discourse analytic approach to examine the structure of clinical consultation as an activity type. 25 clinical consultation sessions between non-native speakers of English in a public healthcare centre in Malaysia were audio-recorded. FINDINGS & DISCUSSION The results show that there are some deviations from the mainstream structure of clinical consultations although, in general, the pattern is compatible with previous studies. Deviations are particularly marked in the opening and closing phases of consultation. CONCLUSION In almost all interactions, there is a straightforward manner of beginning medical consultations. The absence of greetings may have naturally reduced the length of talk. Hence, by directly entering medical talks, the doctors voice their concern on the curing aspects of the consultation rather than its caring facets. The preference of curing priority to caring is more goal-oriented and in alignment with the consultation as an activity type.
Collapse
Affiliation(s)
- H Bagheri
- 1. Universiti Teknologi Malaysia 2. Zahedan University of Medical Sciences.
| | | | | |
Collapse
|
24
|
Bagheri H, Garraffo R, Dellamonica P. From antiretroviral originator to generic drugs: bioequivalence and pharmacovigilance. Med Mal Infect 2014; 44:464-9. [PMID: 25234382 DOI: 10.1016/j.medmal.2014.08.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2014] [Revised: 06/05/2014] [Accepted: 08/06/2014] [Indexed: 10/24/2022]
Abstract
UNLABELLED Antiretroviral drugs have been available in generic form in developing countries, which has expanded access to treatment; they have also become available in developed countries more recently. OBJECTIVES The validation of generic drugs (GD) compared to originator drugs (OD) is mandatory to ensure that using generics will lead to a decreased cost of treatment. RESULTS The results were obtained by analyzing published data as well as European Medicines Agency recommendations. METHOD The GD should have the same qualitative and quantitative active principle formula, the same pharmaceutical forms, and the same criteria in terms of quality, effectiveness, and safety. This equivalence is based on bioequivalence rules: comparison of the concentration/time curves (AUC); Cmax and Tmax (90%), for which the confidence intervals in the range of 80-125% should be included. Naturally, that does not mean that the concentrations can vary from 80 to 125%: this would indicate unacceptable deviations. Conforming to these criteria allows substituting an OD by a GD. Adverse effects should not be different from those observed for the OD. Adverse effects observed when the GD is used must be notified, as is the case for the OD. Accountability is established according to 4 essential pieces of information: a prescriber, a patient, a drug, and an adverse effect. It is sometimes difficult to identify the provider of the GD that has been delivered. CONCLUSION The level of safety concerning effectiveness and tolerance required is identical for OD and GD, in Europe. Analyzing confirmed adverse effects and therapeutic failures is the only way to identify differences that could question a GD's effectiveness.
Collapse
Affiliation(s)
- H Bagheri
- Équipe de pharmacoépidémiologie de l'Inserm U1027, service de pharmacologie clinique, centre Midi-Pyrénées de pharmacovigilance, de pharmacoépidémiologie et d'informations sur le médicament (CRPV), faculté de médecine, CHU de Toulouse, 37, allées Jules-Guesde, 31000 Toulouse, France
| | - R Garraffo
- Laboratoire de pharmacologie, université de Nice-Sophia-Antipolis, hôpital Pasteur, CHU de Nice, CS 51069, 06001 Nice cedex 1, France
| | - P Dellamonica
- Service d'infectiologie, université Nice-Sophia-Antipolis, hôpital Archet 1, CHU de Nice, CS 23079, 06202 Nice cedex 3, France.
| |
Collapse
|
25
|
Abou Taam M, Rossard C, Cantaloube L, Bouscaren N, Roche G, Pochard L, Montastruc F, Herxheimer A, Montastruc JL, Bagheri H. Analysis of patients' narratives posted on social media websites on benfluorex's (Mediator®
) withdrawal in France. J Clin Pharm Ther 2013; 39:53-5. [DOI: 10.1111/jcpt.12103] [Citation(s) in RCA: 34] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2013] [Accepted: 09/16/2013] [Indexed: 12/01/2022]
Affiliation(s)
- M. Abou Taam
- Department of pharmacology; Faculty of Medicine; Centre of Pharmacovigilance; Université de Toulouse; INSERM U 1027; Toulouse France
| | - C. Rossard
- Department of pharmacology; Faculty of Medicine; Centre of Pharmacovigilance; Université de Toulouse; INSERM U 1027; Toulouse France
| | - L. Cantaloube
- Department of pharmacology; Faculty of Medicine; Centre of Pharmacovigilance; Université de Toulouse; INSERM U 1027; Toulouse France
| | - N. Bouscaren
- Department of pharmacology; Faculty of Medicine; Centre of Pharmacovigilance; Université de Toulouse; INSERM U 1027; Toulouse France
| | - G. Roche
- Department of pharmacology; Faculty of Medicine; Centre of Pharmacovigilance; Université de Toulouse; INSERM U 1027; Toulouse France
| | - L. Pochard
- Department of pharmacology; Faculty of Medicine; Centre of Pharmacovigilance; Université de Toulouse; INSERM U 1027; Toulouse France
| | - F. Montastruc
- Department of pharmacology; Faculty of Medicine; Centre of Pharmacovigilance; Université de Toulouse; INSERM U 1027; Toulouse France
| | | | - J. L. Montastruc
- Department of pharmacology; Faculty of Medicine; Centre of Pharmacovigilance; Université de Toulouse; INSERM U 1027; Toulouse France
| | - H. Bagheri
- Department of pharmacology; Faculty of Medicine; Centre of Pharmacovigilance; Université de Toulouse; INSERM U 1027; Toulouse France
| |
Collapse
|
26
|
Ghasemi M, Bagheri H, Olyaei G, Talebian S, Shadmehr A, Jalaei S, Kalantari KK. Effects of cyclic static stretch on fatigue recovery of triceps surae in female basketball players. Biol Sport 2013; 30:97-102. [PMID: 24744474 PMCID: PMC3944585 DOI: 10.5604/20831862.1044224] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/15/2012] [Indexed: 11/13/2022] Open
Abstract
Static stretch is a safe and feasible method which usually is used before exercise to avoid muscle injury and to improve muscle performance. The purpose of this study was to determine the effects of cyclic static stretch (CSS) on fatigue recovery of triceps surae (TS) in female basketball players. Nine athlete volunteers between 20 and 30 years participated in this study containing two sessions. After warm-up a pressure cuff was fastened above the knee joint and its pressure was increased to 140 mmHg. The subjects were asked to perform one maximum voluntary contraction (MVC) followed by a fatigue test including maximum isometric fatiguing contraction of TS. These steps were similar in both sessions. Then, a two-minute rest was included in the first session while 4 static stretches were performed to TS in the second session. After interventions, one MVC was done and the pressure cuff was released. During these steps, peak torque (PT) and electromyography (EMG) were recorded. The amount of lower leg pain was determined by the visual analogue scale (VAS). The value of PT increased significantly after CSS but its increase was not significant after rest. It seems that the effects of rest and CSS on the EMG parameters, PT and pain are similar.
Collapse
Affiliation(s)
- M Ghasemi
- Department of Physiotherapy, Faculty of Rehabilitation Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - H Bagheri
- Department of Physiotherapy, Rehabilitation Faculty, Tehran University of Medical Sciences, Tehran, Iran
| | - G Olyaei
- Department of Physiotherapy, Rehabilitation Faculty, Tehran University of Medical Sciences, Tehran, Iran
| | - S Talebian
- Department of Physiotherapy, Rehabilitation Faculty, Tehran University of Medical Sciences, Tehran, Iran
| | - A Shadmehr
- Department of Physiotherapy, Rehabilitation Faculty, Tehran University of Medical Sciences, Tehran, Iran
| | - S Jalaei
- Department of Physiotherapy, Rehabilitation Faculty, Tehran University of Medical Sciences, Tehran, Iran
| | - K K Kalantari
- Department of Physiotherapy, Faculty of Rehabilitation Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| |
Collapse
|
27
|
Pugnet G, Astudillo L, Bouchet J, Granier C, Bagheri H, Montastruc JL, Sailler L, Arlet P. La gynécomastie douloureuse : un effet indésirable rare du méthotrexate chez un patient atteint de polyarthrite rhumatoïde. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.03.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
28
|
Bibas N, Sartor V, Bulai Livideanu C, Bagheri H, Nougué J, Giordano-Labadie F, Maza A, Paul C, Chouini-Lalanne N, Marguery MC. Contact Photoallergy to Isothipendyl Chlorhydrate. Dermatology 2012; 224:289-91. [DOI: 10.1159/000338024] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2011] [Accepted: 03/13/2012] [Indexed: 11/19/2022] Open
|
29
|
Bagheri H, Nekoomanesh M, Hakim S, Jahani Y, Fan ZQ. Structural parameters in relation to the rheological behavior and properties of PP/EPR in-reactor alloy synthesized by multi-stage sequential polymerization. J Appl Polym Sci 2011. [DOI: 10.1002/app.33951] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
30
|
Bastani A, Hadian MR, Talebian S, Bagheri H, Olyaie GR. Modulation of the ipsilateral and contralateral H reflexes following ipsilateral mechanical pressure of the foot in normal subjects. Electromyogr Clin Neurophysiol 2010; 50:251-256. [PMID: 20718337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
OBJECTIVE Mechanoreceptors from the foot sole likely contribute in the reflex regulations. Therefore, it was hypothesized that repetitive low threshold afferents stimulation would have an inhibitory effect on the soleus H-reflexes. METHODS Sixteen normal subjects voluntarily, participated in the study and were randomly allocated. Subjects were remained in prone position. The Cutaneous Mechanical Pressure (CMP equal to 50% of leg and foot weight) was applied to the ipsilateral lateral and Medial plantar surface by a designed instrument through a square plate (30 x 30 mm). H reflex as an indicator for excitability of motoneurones was bilaterally elicited before and after the application of the CMP. The H-reflex parameters were estimated. RESULTS Mechanical pressure significantly depressed soleus H-reflex excitability in ipsilateral and contralateral feet in all subjects. CONCLUSION The demonstration of a decrease in H-reflex excitability as a result of applied pressure to the foot sole suggests that the change in reflex excitability is the result of a common spinal mechanism. The results highlight the modulatory effects that natural stimulation of afferents can have on reflex excitability. SIGNIFICANCE The placement of a small flat plate, in order to apply pressure to the plantar eminence, may be useful for modulation of muscle tone. In addition, these findings might be useful for reducing spasticity; because spasticity is at least partially caused by hyperexcitability of the motorneuron pool.
Collapse
Affiliation(s)
- A Bastani
- Tehran University of Medical Sciences, Faculty of Rehabilitation, Pich-Shemiran, Tehran, Iran.
| | | | | | | | | |
Collapse
|
31
|
Shadmehr A, Bagheri H, Ansari NN, Sarafraz H. The reliability measurements of lateral scapular slide test at three different degrees of shoulder joint abduction. Br J Sports Med 2010; 44:289-93. [PMID: 18812417 DOI: 10.1136/bjsm.2008.050872] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
BACKGROUND Lateral scapular slide test (LSST) quantitatively measures the distance between thoracic spine (T7) and inferior angle of scapula. OBJECTIVE In this study, the intra-rater reliability, inter-rater reliability and diagnostic accuracy of LSST were measured using a caliper. METHODS Three measurements of each test position were obtained bilaterally. Intraclass correlation coefficient (ICC) (2.1), 95% CI and 2 SEMs were calculated for intra-rater and inter-rater reliability of the absolute scapular distance. Sensitivity, specificity, positive and negative likelihood ratios were determined. RESULTS 27 people with and 30 people without shoulder pain participated. The mean age (SD) for the participant was 47.7 (11.6) years and 33.5 (11.7) years, respectively. The ICCs for intra-rater reliability were high. A range of poor to good ICCs was found for inter-rater reliability. The 2 SEMs ranged from 4.6 to 7.9 mm for intra-rater reliability and from 6.8 to 13.4 mm for inter-rater reliability for people with shoulder pain. Positive and negative likelihood ratios from 0.94 to 1.22 and from 0.21 to 2.5, respectively, were demonstrated. CONCLUSION SST did not show a consistent high reliability. The diagnostic accuracy of the LSST was low, which questions the clinical importance of the tests outcomes.
Collapse
Affiliation(s)
- A Shadmehr
- Department of Physiotherapy, Faculty of Rehabilitation, University of Tehran (Medical Sciences), Piche-Shemiran, Enghelab Ave, Tehran 11489-65141, Iran
| | | | | | | |
Collapse
|
32
|
Mariette X, Tubach F, Bagheri H, Bardet M, Berthelot JM, Gaudin P, Heresbach D, Martin A, Schaeverbeke T, Salmon D, Lemann M, Hermine O, Raphael M, Ravaud P. Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry. Ann Rheum Dis 2010; 69:400-8. [PMID: 19828563 PMCID: PMC2925048 DOI: 10.1136/ard.2009.117762] [Citation(s) in RCA: 142] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
OBJECTIVE To describe cases of lymphoma associated with anti-TNF therapy, identify risk factors, estimate the incidence and compare the risks for different anti-TNF agents. METHODS A national prospective registry was designed (Research Axed on Tolerance of bIOtherapies; RATIO) to collect all cases of lymphoma in French patients receiving anti-TNF therapy from 2004 to 2006, whatever the indication. A case-control analysis was conducted including two controls treated with anti-TNF per case and an incidence study of lymphoma with the French population was used as the reference. RESULTS 38 cases of lymphoma, 31 non-Hodgkin's lymphoma (NHL) (26 B cell and five T cell), five Hodgkin's lymphoma (HL) and two Hodgkin's-like lymphoma were collected. Epstein-Barr virus was detected in both of two Hodgkin's-like lymphoma, three of five HL and one NHL. Patients receiving adalimumab or infliximab had a higher risk than those treated with etanercept: standardised incidence ratio (SIR) 4.1 (2.3-7.1) and 3.6 (2.3-5.6) versus 0.9 (0.4-1.8). The exposure to adalimumab or infliximab versus etanercept was an independent risk factor for lymphoma in the case-control study: odds ratio 4.7 (1.3-17.7) and 4.1 (1.4-12.5), respectively. The sex and age-adjusted incidence rate of lymphoma was 42.1 per 100 000 patient-years. The SIR was 2.4 (95% CI 1.7 to 3.2). CONCLUSION The two to threefold increased risk of lymphoma in patients receiving anti-TNF therapy is similar to that expected for such patients with severe inflammatory diseases. Some lymphomas associated with immunosuppression may occur, and the risk of lymphoma is higher with monoclonal-antibody therapy than with soluble-receptor therapy.
Collapse
Affiliation(s)
- X Mariette
- Hôpital de Bicêtre, Le Kremlin Bicêtre, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Pugnet G, Forgues M, Michaud M, Astudillo L, Bagheri H, Montastruc JL, Arlet P, Sailler L. La flecaïnide : un médicament inducteur de lupus ? Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.03.168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
34
|
Pugnet G, Ysebaert L, Bagheri H, Montastruc JL, Laurent G. Purpura thrombopénique auto-immun faisant suite à une vaccination par le vaccin quadrivalent Papillomavirus humain. Rev Med Interne 2009. [DOI: 10.1016/j.revmed.2009.03.232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
35
|
|
36
|
Abstract
Nefopam is widely used for the relief of moderate acute pain. Its safety profile remains to be specified. The objective of the study was to review adverse reactions to nefopam spontaneously reported to the French Pharmacovigilance system. All cases of adverse drug reactions (ADRs) associated with nefopam, registered in the French Pharmacovigilance database from January 1, 1995 to December 31, 2004, were reviewed. For each reported ADR, information about patient (age, gender, medical history), drug exposure (suspected and concomitantly used drugs), characteristics of ADRs (imputability score, time of onset, seriousness, outcome) were collected. A total of 114 ADRs with an imputability rated from 'plausible' (I2) to 'likely' (I3) and 'very likely' (I4) was analysed. The most frequent ADRs included 'expected' ADRs such as sweating, nausea, tachycardia, malaise or vomiting; 61 ADRs were 'unexpected. No overdose was reported; 26 ADRs (23%) were considered as 'serious'. Most of them were 'unexpected', including neuropsychiatric (hallucinations, convulsions) or cutaneous (pruritus, erythema, urticaria) ADRs. Six cases of anaphylactic ADRs (two angioedema and four anaphylactic shocks) were reported, all occurring shortly after use of nefopam during the post-operative period. Physicians should be aware of the possible occurrence of some serious ADRs when using nefopam such as convulsions and anaphylactic shocks, especially when the drug is used in special medical conditions, like post-operative periods.
Collapse
Affiliation(s)
- G Durrieu
- Service de Pharmacologie Clinique, Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
| | | | | | | |
Collapse
|
37
|
Ansari NN, Naghdi S, Bagheri H, Ghassabi H. Therapeutic ultrasound in the treatment of ankle plantarflexor spasticity in a unilateral stroke population: a randomized, single-blind, placebo-controlled trial. Electromyogr Clin Neurophysiol 2007; 47:137-43. [PMID: 17557646 DOI: pmid/17557646] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Spasticity is a common and disabling symptom associated with Upper Motor Neuron Syndrome. The current methods of treatment for muscle spasticity have been claimed as unsatisfactory. Therapeutic ultrasound (US) is a common therapeutic modality in physiotherapy used for treating a wide variety of disorders. The aim of present study was to quantify the effects of continuous US on ankle plantarflexor spasticity in a randomized, single-blind, placebo-controlled trial. Twelve stroke patients (6 women and 6 men) randomly allocated to ultrasound (n = 6) or placebo (n = 6) groups. The patients were treated with either US or sham US for three days per week, every other day for 15 treatment sessions. The primary efficacy measures were the H-reflex and the Ashworth Scale (AS). In experimental group there was a significant reduction in the Hmax/Mmax ratio (p = 0.03). The Hmax/Mmax ratio was increased in the placebo group patients (p > 0.05). The difference between two groups was statistically significant (p = 0. 02). In both groups there was a reduction in the posttreatment AS scores. The Ashworth scores demonstrated statistically significant changes in the US group (p = 0.04). There was no statistical difference, however, when these two groups were compared (p > 0.05). Results from the present study show that treatment with US can reduce HmaxlMmax ratio as a measure of alpha motoneuron excitability and spasticity measure of AS in stroke patients with ankle plantarflexor spasticity.
Collapse
Affiliation(s)
- N N Ansari
- Associate Professor, Rehabilitation Faculty, Tehran University of Medical Sciences, Iran.
| | | | | | | |
Collapse
|
38
|
Hatef B, Talebain S, Oliyae G, Bagheri H. Effect of Tempromandibular Joint Sounds on Timing of the Masseter Muscle Activity in the Open-close-clench Cycle. J of Medical Sciences 2007. [DOI: 10.3923/jms.2007.339.346] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
39
|
Bagheri H, Memarian R, Alhani F. Evaluation of the effect of group counselling on post myocardial infarction patients: determined by an analysis of quality of life. J Clin Nurs 2007; 16:402-6. [PMID: 17239076 DOI: 10.1111/j.1365-2702.2005.01498.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
AIM AND OBJECTIVE The aim of this study was to investigate the effect of group counselling program on quality of life in survivors of myocardial infarction. BACKGROUND Myocardial infarction is one of the most dramatic illnesses that can afflict patients. Despite decreases in mortality from coronary heart disease in most developed countries, mortality is increasing in most eastern European countries and developing countries. DESIGN A randomized-controlled trial design. METHODS Sixty-two patients with myocardial infarction were chosen, case group, (31 patients), distributed in five subgroup (each subgroup conclude six or seven patients) and control group (31 patients). A group-counselling program was performed two days per week, each session last one hour. However, no counselling was performed for the control group. The quality of life score was estimated in both groups by the use of the MacNew Quality of Life after Myocardial Infarction questionnaire, before the group counselling program, and one month after the group counselling program, and the quality of life between both groups were compared. The data were analyzed using SPSS software. RESULTS Results indicated that there was no significant difference between the mean quality of life score of case and control groups before group counselling program. While there was a significant difference (P = 0.001) between the mean of quality of life score after the group counselling in both groups. The mean of quality of life score, before and after group counselling program indicated a significant difference (P < 0.001) in the case group, while there was no significant difference in the control group. The statistical comparison of the mean of quality of life score in general and in each dimensions before and after group counselling program indicated that there was a significant difference between before and after group counselling in the case group whereas in the control group it has slightly decreased. Pearson's correlation coefficient test (P = 0.002) showed a significant correlation between the duration of myocardial infraction and the quality of life score. The effectiveness of the planned counselling program on quality of life was estimated 24.08 by growth test. CONCLUSION As indicated by the results of this study, group counselling program can promote patient's quality of life in all dimensions. RELEVANCE TO CLINICAL PRACTICE There is a need for nurses and physicians to apply group counselling program in a wide variety of settings ranging from community to intensive care, as a simple and safe intervention to promote patient's quality of life.
Collapse
Affiliation(s)
- H Bagheri
- Department of nursing, Shahroud faculty of medical Sciences, Shahroud, Iran.
| | | | | |
Collapse
|
40
|
Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Sommet A, Lapeyre-Mestre M, Muoz MJ, Sie P, Honorato J, Montastruc JL, Bagheri H. Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 2007; 63:221-8. [PMID: 17225990 DOI: 10.1007/s00228-006-0242-8] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2006] [Accepted: 11/20/2006] [Indexed: 10/23/2022]
Abstract
AIMS Our objectives were to assess the detection and incidence of drug-induced agranulocytosis in two university hospitals using hematology laboratory data. METHODS A prospective study was undertaken at Toulouse University Hospital (France) and Navarra University Hospital (Spain) for 1 year (from 1 May 2004 to 30 April 2005). Using a computerized process and hematology laboratory data, all neutrophil counts with a value less than 500/mm(3) were registered, allowing identification of inpatients suffering from agranulocytosis during the period of the study. Medical records of all selected patients were then consulted. Cytostatic drugs were excluded from this study. RESULTS During the period of the study, 225,659 neutrophil counts were performed in both hospitals, of which 2,835 (1.26%) had a neutrophil count less than 500/mm(3), corresponding to 739 patients. Seventeen patients were excluded because of lack of data, and 20 cases of infants younger than 3 months were excluded. Among the remaining patients (n = 702), 23 cases of drug-induced agranulocytosis (excluding cytostatic drugs) were suspected. All cases were classified as "serious" since they led to death in 2 cases, hospitalization or prolongation of hospitalization in 19 cases and threatening of vital prognosis in 2 cases. Withdrawal of suspected drugs was done in all cases with regression of neutropenia in 21 cases. According to hospitalization data, the annual incidence of drug-induced agranulocytosis was 1.62 (1.0-2.6) per 10,000 inpatients in Toulouse University hospital (based on 534 cases) and 3.24 (0.9-8.3) per 10,000 inpatients in Navarra University Hospital (based on 168 cases). The involved drugs were mainly antibacterial (30.4%), immunosuppressive (17.4%), antithyroid (13.0%), antiplatelet (8.7%) and nonsteroidal anti-inflammatory (8.7%) ones. Only seven cases from Toulouse University Hospital were spontaneously reported by physicians during the same period. Thus, the underreporting coefficient (U) was 2.71 (63.2%) in France. CONCLUSION Our survey allowed us to identify the suspected drug-induced agranulocytosis through a prospective study in a large sample of inpatients using only laboratory data analysis. We also note an important underreporting rate of this serious adverse drug reaction (ADR) to the official French pharmacovigilance system. Laboratory data analysis could be used for identifying serious ADRs.
Collapse
Affiliation(s)
- N Tavassoli
- Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'informations sur le Médicament, Unité de Pharmacoépidémiologie EA 3696, Université Paul Sabatier, Faculté de Médecine, Toulouse, France
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Le Beller C, Bagheri H, Lillo-Le Louet A. When the Comparison of Spontaneous Notification Rates Helps Us to Evaluate a Signal. Drug Saf 2007. [DOI: 10.2165/00002018-200730100-00022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
42
|
Biboulet M, Montastruc JL, Bagheri H. Central Adverse Drug Reactions (ADRs) Induced by Non Neuropsychotropic Drugs: A Survey on French PharmacoVigilance Database. Drug Saf 2007. [DOI: 10.2165/00002018-200730100-00096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
43
|
Abstract
The authors describe a case of valvular heart disease in a 48-year-old woman receiving benfluorex (150 mg t.i.d. for 8 years) and leading to surgical mitral valve replacement. Examination showed severe dyspnea with severe mitral regurgitation associated with tricuspid regurgitation. No other common disease known to affect mitral valves nor intake of other drugs (ergot derivatives or appetite suppressant drugs) was found. The paper discusses the imputability of benfluorex, a drug used as an adjuvant in hypercholesterolemia, structurally related to amphetamines.
Collapse
Affiliation(s)
- P Noize
- Service de Pharmacologie Clinique, Centre Midi-Pyrénées de PharmacoVigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, CHU, Faculté de Médecine, Université Paul Sabatier, 37 allées Jules Guesde, 31000 Toulouse, France
| | | | | | | | | | | | | |
Collapse
|
44
|
Ghotbi N, Olyaei GR, Hadian MR, Ansari NN, Bagheri H. Is there any relationship between the Modified Ashworth Scale scores and alpha motoneuron excitability indicators? Electromyogr Clin Neurophysiol 2006; 46:279-84. [PMID: 17059100 DOI: pmid/17059100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
The purpose of this study was to investigate the relationship between the modified Ashworth scale (MAS) scores and alpha motoneuron excitability indicators. Thirty-one post-stroke patients were assessed for this object. The main outcome measures were the MAS and electro physiologic assessments. The latter was performed using both conventional (Hmax/Mmax) and new (Hslope/Mslope) measures of spinal excitability. Data on thirty-one adult subjects with hemiplegia (twenty-five men and six women) were analysed. The soleus Hmax/Mmax ratio appeared to correlate directly with the MAS scores (r = 0.36; P < 0.05). Correlation between the MAS scores and either Hslope/Mslope ratio or H-reflex latency was not significant (P > 0.05). In seventeen patients whose H-reflex could be evoked bilaterally, spinal excitability indicators showed significant difference between the affected and non-affected sides (P < 0.05). Based on the results of this study, there is no relationship between the MAS scores and the preferred measure of alpha motoneuron excitability. This research suggests that the MAS could not distinguish between the reflexive and non-reflexive components of the hypertonicity in ankle plantar flexors.
Collapse
Affiliation(s)
- N Ghotbi
- Tehran University of Medical Sciences, Faculty of Rehabilitation, Iran
| | | | | | | | | |
Collapse
|
45
|
Michenot F, Sommet A, Bagheri H, Lapeyre-Mestre M, Montastruc JL. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: a study from the French PharmacoVigilance Database. Pharmacoepidemiol Drug Saf 2006; 15:735-40. [PMID: 16924603 DOI: 10.1002/pds.1284] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE To evaluate adverse drug reactions (ADRs) in patients older than 70 years reported during the 2003 summer heat wave in France to the French Network of Pharmacovigilance Centres and to discuss the interest of such a pharmacovigilance database in the surveillance of such sanitary alerts. METHODS All 'serious' ADRs occurred in patients older than 70 years between 1st July and 31st August 2003, reported to the French network of Pharmacovigilance Centres and recorded in the French PharmacoVigilance Database, were analysed with respect to age, gender, type of ADR, drug(s) involved as well as imputability of heat wave. RESULTS The total number of 'serious' ADRs registered in the French PharmacoVigilance Database in patients older than 70 years was similar in 2003 (a year with heat wave) and in 2002 (a year without heat wave). Sixty-eight ADRs [27 'possible' (I1), 27 'plausible' (I2) and 14 'likely' (I3)] related to heat occurred in 2003, with a maximal peak between the 28th July and the 17th August. The most frequently ADRs were metabolic (dehydratation, hydroelectrolytic disturbances) and neuropsychiatric (confusion, falls, coma). Drugs more frequently involved were diuretics, angiotensin converting enzyme inhibitors, antidepressants (mainly serotonin reuptake inhibitors), proton pump inhibitors, digoxin, benzodiazepines, oral hypoglycemics and sartans. CONCLUSION This study underlines the role of heat wave in the occurrence of 'serious' ADRs in elderly. However, the French PharmacoVigilance Database was not enough sensitive to be used as an efficient surveillance system during such an acute episode, like a heat wave (at least while underreporting remains so important).
Collapse
Affiliation(s)
- F Michenot
- Service de Pharmacologie Clinique, Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, Centre Hospitalier Universitaire de Toulouse, France
| | | | | | | | | |
Collapse
|
46
|
Guitton E, Barange K, Bagheri H, Montastruc JL, Vinel JP, Claeyssens S, Bonnet E, Massip P. Blood transaminase elevation with pegylated interferon alfa 2b plus ribavirin in an HIV/HCV coinfected haemophilic patient. Infection 2006; 34:183-5. [PMID: 16804666 DOI: 10.1007/s15010-006-5016-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2005] [Accepted: 04/11/2006] [Indexed: 11/29/2022]
|
47
|
Tavassoli N, Duchayne E, Sadaba B, Desboeuf K, Lapeyre-Mestre M, Muoz M, Sie P, Honorato J, Montastruc JL, Bagheri H. Detection and Incidence of Drug-Induced Agranulocytosis in French and Spanish Hospital: a Prospective Analysis from Laboratory Signals. Drug Saf 2006. [DOI: 10.2165/00002018-200629100-00054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
48
|
Pichereau J, Pathak A, Lacroix I, Bagheri H, Montastruc J, Damase-Michel C. Perception of Teratogenic and Foetotoxic Risk by Health Professionals: a Survey in Midi-Pyrenees Area. Drug Saf 2006. [DOI: 10.2165/00002018-200629100-00124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
49
|
Affiliation(s)
- A Pathak
- Service de Pharmacologie Clinique, Faculté de Médecine, BP 7202, 31073 Toulouse Cedex 7, France
| | | | | | | | | | | | | |
Collapse
|
50
|
Dugué A, Bagheri H, Lapeyre-Mestre M, Tournamille JF, Sailler L, Dedieu G, Salvayre R, Thouvenot JP, Massip P, Montastruc JL. Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals. Eur J Clin Pharmacol 2004; 60:285-92. [PMID: 15114428 DOI: 10.1007/s00228-004-0760-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2003] [Accepted: 03/04/2004] [Indexed: 10/26/2022]
Abstract
AIMS The awareness of muscular adverse drug reactions (ADRs) increased since the withdrawal of cerivastatin, a HMG-CoA reductase inhibitor, from the market in August 2001. Our objectives were to assess the detection and incidence of muscular ADRs in a University Hospital using biochemical laboratory data and to evaluate the underreporting rate of drug-induced muscular disorders. METHODS A prospective study was undertaken at Toulouse University Hospital, France, for 1 week per month from November 2001 to October 2002. Patients were selected by means of a computerized process using biochemical laboratory data based on serum creatine phosphokinase (CPK) values (over twofold normal). Medical records of all selected patients were then consulted. RESULTS During the period of the study, 2017 CPK tests were performed, among which 171 values were over twofold normal corresponding to 129 patients. Because of lack of data, 26 patients were excluded. Among these patients ( n=103), 28 cases of muscular ADRs were suspected, 22 of which were detected in outpatient departments. Four patients were totally asymptomatic and five had an increase of CPK over fivefold normal. Nine cases were classified as "serious". Withdrawal of suspected drugs were done in 16 cases with regression of ADRs in 13 cases. According to hospitalization data, the incidence of muscular ADRs was estimated as 7.2 (2.6-15.7) per 10,000 inpatients and 9.3 (5.8-14.1) per 10,000 outpatients over 12 weeks. The involved drugs were mainly: statins (46.4%), fibrates (14.3%), antiretrovirals (14.3%), angiotensin-II receptor antagonists (10.7%), immunosuppressants (7.1%) or hydroxychloroquine (7.1). Only two cases, judged as "serious", were spontaneously reported by physicians during the same period. CONCLUSION The results of this survey underline the importance to take into account drug hypothesis in muscular injuries diagnosis.
Collapse
Affiliation(s)
- A Dugué
- Centre Midi-Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d'informations sur le Médicament, Centre Hospitalier Universitaire, Faculté de Médecine, 37 allées Jules Guesde, BP 7202, 31073 Toulouse Cedex 7, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|